Back to Trades
Smith Darren Charlton
Group Chief Financial OfficerCIK 0002122447
Profile
- Filings
- 3
- Buy transactions
- 1
- Sell transactions
- 0
- Companies
- 1
- Active
- 2026
Across 3 filings between 2026, Smith Darren Charlton, Group Chief Financial Officer, has disclosed $20.0K in transactions — all concentrated in Telix Pharmaceuticals Ltd (TLX). Their disclosed trades are heavily weighted toward buying — $20.0K in buys and $0 in sells. The largest single open-market purchase on record is $20.0K in Telix Pharmaceuticals Ltd. Data is sourced from official SEC Form 3, 4, and 5 filings.
Associated Companies
Trading History
3 loaded
| Sep 14 | TLX Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group Chief Financial Officer | Buy | $20.0K |
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group Chief Financial Officer | Exercise | $0 |
| Apr 1 | TLX Telix Pharmaceuticals Ltd | Smith Darren Charlton | Group Chief Financial Officer | Other | $0 |
3 filings